Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). [3]
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Tasuku Honjo. The Nobel Prize in Physiology or Medicine 2018. Born: 27 January 1942, Kyoto, Japan. Affiliation at the time of the award: Kyoto University, Kyoto, Japan. Prize motivation: “for their discovery of cancer therapy by inhibition of negative immune regulation”. Prize share: 1/2.
May 9, 2024 · Tasuku Honjo (born January 27, 1942, Kyoto, Japan) is a Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer.
However, a new treatment cancer therapy born out of research by the 2018 medicine laureates James Allison and Tasuku Honjo, offered him fresh hope. Dahl received a type of immunotherapy drug that uses the power of the body’s own immune system to control, and eliminate cancer, to give him “the gift of life”.
Oct 1, 2018 · James Allison and Tasuku Honjo pioneered treatments that unleash the body’s own immune system to attack cancer cells.
1968. Adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis by diphtheria toxin. T Honjo, Y Nishizuka, I Kato, O Hayaishi. Journal of Biological Chemistry 246 (13), 4251-4260.
Related searches
